علاج متلازمة أضداد الفوسفوليبيد في متلازمة أضداد الفوسفوليبيد الكارثية

References

• For first-line treatment of patients with CAPS, combination therapy with glucocorticoids, heparin and plasma exchange or intravenous immunoglobulins is recommended over single agents or other combinations of therapies.
• In patients with refractory CAPS, B cell depletion (eg, rituximab) or complement inhibition (eg, eculizumab) therapies may be considered.